Records containing: Vaccine
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-11-02Evaluation of Menstrual Irregularities and Abnormal Uterine Bleeding After Covid-19 Vaccine
-
CLINICAL_TRIALS study record update · 2022-09-14HPV Message Testing and Social Media Campaign
-
CLINICAL_TRIALS study record update · 2022-04-08Maternal to Neonatal Transmission Antibody Covid-19 Study - The TRAB CoV-19
-
CLINICAL_TRIALS study record update · 2022-02-28Understanding Immunity to the COVID-19 Vaccines
-
CLINICAL_TRIALS study record update · 2021-12-09Gut Microbiota, the Potential Key to Modulating Humoral Immunogenicity of New Platform COVID-19 Vaccines: Adenovirus-vectored Vaccine Versus mRNA Vaccine
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-11-12Double-blind, Placebo-controlled, Randomized Study of Tolerability, Safety and Immunogenicity of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine, Produced by FSBSI "Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products", on Volunteers at the Age of 18-60 Years
-
CLINICAL_TRIALS study record update · 2021-10-20The Efficacy of COVID-19 Vaccine in Patients With HIV Infection，a Prospective and Multicenter Clinical Trial
-
CLINICAL_TRIALS study record update · 2021-07-20Safety and Immunogenicity of 2-dose Inactivated COVID-19 Vaccine in Kidney Transplant Recipients: a Prospective Cohort Study
-
CLINICAL_TRIALS study record update · 2021-07-14Immunogenicity of the ChAdox1 n CoV-19 Vaccine Against SARS-CoV-2 With 12-dose Vials: an Interim Analysis
-
CLINICAL_TRIALS study record update · 2021-02-21A Phase 1, Randomized, Controlled, Observer-blind Study to Assess the Reactogenicity, Safety, and Immunogenicity of a Live Attenuated Universal Influenza Vaccine (cH8/1N1 LAIV) Administered as a Single Priming Dose Followed Three Months Later by a Single Booster Dose of an Inactivated Universal Influenza Vaccine (cH5/1N1 IIV) (Adjuvanted With AS03A or Unadjuvanted) in 18 Through 39 Year-old Healthy Subjects, Contrasted With a Two Dose Schedule of an Inactivated Universal Influenza Vaccine (cH8/1N1 IIV + AS03A Followed Three Months Later by cH5/1N1 IIV + AS03A)
-
CLINICAL_TRIALS study record update · 2021-02-05Longidutinal, Dynamic Analysis of COVID-19 Vaccine Induced Adaptive Immune Responses
-
CLINICAL_TRIALS study record update · 2020-12-10A Randomized, Controlled, Multicenter Phase 4 Clinic Trial to Evaluate the Immunogenicity and Safety of Combined Immunization of Sabin-strain Inactivated Polio Vaccine (sIPV), Diphtheria, Tetanus, Pertussis Vaccine (DTaP) and Measles, Moms and Rubella Vaccine (MMR)
-
CLINICAL_TRIALS study record update · 2020-08-20State Immunization Information Systems to Improve HPV Vaccination Rates
-
CLINICAL_TRIALS study record update · 2019-02-22Rubella Susceptibility in Multiparous Women
-
CLINICAL_TRIALS study record update · 2019-02-22Acceptability and Feasibility of Influenza Vaccine Administration on the Post-partum Floor Prior to Discharge Home During Flu Season
-
CLINICAL_TRIALS study record update · 2018-10-22Immunogenicity and Safety of Bivalent Meningococcal Serogroups A and C Tetanus Toxoid Conjugate Vaccine in Chinese Healthy Children Aged 3 Months to 5 Years.: A Randomized, Blinded, Positive Controlled Phase III Clinical Trial
-
CLINICAL_TRIALS study record update · 2017-09-29Phase 3 Study of ASP7374 -Open-label Study of Intramuscular ASP7374 in Adults ≥61 Years of Age-
-
CLINICAL_TRIALS study record update · 2017-09-29Phase III Study of ASP7374-Open-label Study of Subcutaneous Vaccination of Quadrivalent ASP7374 in Adult Subjects Aged 20 or Older
-
CLINICAL_TRIALS study record update · 2017-09-29Phase 3 Study of ASP7374 -Approved Egg-derived Vaccine Controlled, Double-blind, Parallel Group Study in Adults ≥20 and <65 Years of Age-
-
CLINICAL_TRIALS study record update · 2014-09-15A Phase 1, Open-Label, Dose Escalation Study of the Safety and Tolerability of CoVaccine HT™ in Healthy Adult Volunteers
-
CLINICAL_TRIALS study record update · 2013-04-18A Phase IV, Multi-Center, Active-Controlled, Observer-Blind Study to Evaluate the Safety of a Trivalent Subunit Influenza Vaccine Produced Either in Mammalian Cell Culture (Optaflu®) or in Embryonated Hen Eggs (Agrippal®) in Adults and Elderly With and Without Underlying Medical Conditions, and to Evaluate the Immunogenicity in a Subset of Subjects With Underlying Medical Conditions
-
CLINICAL_TRIALS study record update · 2008-04-22A Phase III, Multicenter, Uncontrolled, Open-Label Study to Evaluate Safety and Immunogenicity of Preservative Free, Inactivated Split Influenza Vaccine, Using the Strain Composition 2007/2008 When Administered to Adult and Elderly Subjects